Mr. Gary Augusta has over 25 years of experience in healthcare and other innovative sectors including leadership roles in mergers and acquisitions, capital markets and investments, strategic planning, corporate partnerships, and as a public company Board Director. Mr. Augusta is currently on the Board of Directors of Apollo Medical Holdings, Inc. and has had that position since March 2012. Previous roles at Apollo Medical include President, Executive Chairman and Consultant. Mr. Augusta also currently serves as President of Flacane Advisors focusing on healthcare and technology advisory and investments.
Mr. Augusta served as President of SpaGus Ventures and SpaGus Capital Partners focusing on healthcare and technology investments and advisory services. Additionally, Mr. Augusta was President and CEO of OCTANe, an innovation development company. As a Corporate Officer at Fluor, Inc., a Fortune 500 company, Mr. Augusta focused on Corporate Development and M&A. AT Kearney, a leading global consulting firm, benefited from Mr. Augusta's experience as a Consultant and Principal.
Mr. Augusta earned a BS in Mechanical Engineering from the University of Rhode Island and a Master of Science and Management (MSM) from Georgia Institute of Technology (Georgia Tech).
Dr. Thomas Gill is currently Chairman of Orthopedic Surgery for Steward Healthcare Network, Professor of Orthopaedic Surgery at Tufts University School of Medicine, and Director of the Boston Sports Medicine and Research Institute.
Dr. Gill has served as Medical Director for the Boston Red Sox, Head Team Physician for the New England Patriots, and Team Physician for the Boston Bruins. He is a fellow of the American Association of Orthopaedic Surgeons; a member of the American Orthopaedic Society for Sports Medicine; has been a member of the Team Physician Societies of the Major League Baseball organization, the National Football League, and the National Hockey League; and was elected to the Herodicus Society and the American Orthopedic Association.
Dr. Gill received his medical degree from Harvard Medical School. He performed his internship in general surgery at the Massachusetts General Hospital and completed his orthopedic surgery training at the Harvard Combined Orthopaedic Residency Program. Upon his graduation, Dr. Gill was awarded the Maurice E. Muller Scholarship to study reconstructive surgery in Bern, Switzerland and throughout other European academic centers. He completed his fellowship training in Sports Medicine and Shoulder Surgery at the Steadman-Hawkins Clinic in Vail, Colorado.
Dr. Gill's primary clinical and research interests include knee and shoulder injuries. He has a particular interest in biomechanics of the knee and shoulder, as well as tissue engineering techniques for joint preservation and cartilage repair in the knee. Dr. Gill has authored over 200 peer-reviewed articles and chapters on basic science and clinical issues involving the knee and shoulder and has previously written books on Complications of Shoulder Surgery and Techniques of Knee Arthroscopy.
Mr. Renna is a senior private equity executive with experience in financial and operations management, mergers and acquisitions, fund raising, portfolio management and investor relations across a variety of industries including healthcare services, biotech, pharmaceutical, manufacturing, energy and media. Mr. Renna served as Executive Vice President and Chief Financial Officer at Steward Health Care System, LLC where his management responsibilities include controller, corporate finance, reimbursement, supply chain and decision support.
Mr. Renna holds a BS from Princeton University and an MBA from Duke University.
Sheila has over 30 years of experience in the healthcare industry bringing tremendous depth of experience and success as a C-level executive, investor, and advisor. Sheila is also the founder and serves on the Board of PatientMatters Holding LLC, a technology and patient engagement firm helping healthcare providers manage patient financial obligations. Previously, she was Chairman and CEO of CareMedic, a HCIT revenue cycle management company; COO of MedUnite, a consortium of insurance/managed care companies that created a health data exchange; CEO of Presideo, a biometric security platform for HCIT systems; and SVP Operations of Envoy, the nation's largest healthcare clearinghouse. Sheila is a recognized expert in the healthcare industry and has testified before the U.S. Congress and the Ministers of Health of the European Union on the topic of electronic transaction and claim processing. As an investor and executive, Sheila has been involved in over 40 deals totaling $3 billion.
Sheila served on the boards of Aventura, the leading provider of awareness computing, Recondo Health, and National Electronic Attachment and led its sale to KKR. Sheila was a founding member of WEDI, Workgroup for Electronic Data Interchange, and served on the ANSI X12 committee and participated in the development of the HIPAA legislation. She was Chairperson of AFEHCT, Association for Electronic Healthcare Transactions, and The Medical Banking Project and led the mergers of both with HIMSS. She has also held advisory roles with Aetna, Blue Cross and Blue Shield Association and NDC Health. Sheila holds a BS in Chemistry from Western Kentucky University.